Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 74Colonic Neoplasms 24Colonic Polyps 15Adenoma 14Neoplasms 5Colorectal Neoplasms, Hereditary Nonpolyposis 5Polyps 4Pain 4Gastrointestinal Neoplasms 4Disease 4Adenomatous Polyps 3Stomach Neoplasms 2Peptic Ulcer 2Liver Cirrhosis 2Intestinal Neoplasms 2Intestinal Diseases 2Inflammatory Bowel Diseases 2Gastritis, Atrophic 2Digestive System Diseases 2Colitis, Ulcerative 2Turcot syndrome 1Tuberculosis 1Signs and Symptoms, Digestive 1Recurrence 1Rectal Neoplasms 1Rectal Diseases 1Predictive Cancer Model 1Personal Satisfaction 1Patient Satisfaction 1Pathologic Complete Response 1

Interventions

pembrolizumab 4Trastuzumab 4Oxaliplatin 4Fluorouracil 4Cyclophosphamide 4Carboplatin 4Radiotherapy 3Paclitaxel 3Endoscopy 3Docetaxel 3Cytarabine 3Chemoradiotherapy 3Capecitabine 3toripalimab 2Tretinoin 2Surgical Procedures, Operative 2Standard of Care 2Observation 2Neoadjuvant Therapy 2Metformin 2Magnetic Resonance Imaging 2Leucovorin 2Irinotecan 2Immunotherapy 2Immune Checkpoint Inhibitors 2Epirubicin 2Drug Therapy 2Doxorubicin 2Cisplatin 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pathologic Complete Response × Colonoscopy × Clear all
NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting
394 enrolled

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon âš¡